Source: Annual Congress 2003 - Interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Gingrich, V. Havranek, F. Wantke, I. Herkner, P. Errhalt, F. Kummer, K. Nakata (Vienna, Austria; Tokyo, Japan). Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report. Eur Respir J 2003; 22: Suppl. 45, 403

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar proteinosis therapy success with combined lavage procedures: a case report Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 The benefits of whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 503-505 Year: 2004 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 526-531 Year: 2004 Outpatient lobar lavage: a novel approach to managing pulmonary alveolar proteinosis Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches Year: 2020 BAL cytology in pulmonary alveolar proteinosis: a review of 7 cases Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis Source: Eur Respir J 2012; 39: 1049 Year: 2012 Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage Source: International Congress 2017 – Paediatric bronchology Year: 2017 Pulmonary alveolar proteinosis: report of two cases Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study Source: International Congress 2015 – IIPs: orphan Year: 2015 Whole lung lavage in pulmonary alveolar proteinosis in a young child – a new technique Source: Annual Congress 2009 - Fiberoptic bronchoscopy in the diagnosis of respiratory diseases in children Year: 2009 Long term follow up of the whole lung lavage programme in patients with pulmonary alveolar proteinosis: an update Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Whole lung lavage with intermittent double lung ventilation: a new technique for managing pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 91s Year: 2004 Secondary pulmonary alveolar proteinosis associated with IgG4-related disease Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013